tirzepatide and vision Weight-loss drugs like semaglutide linked to rare loss condition Incretin Mimetrics - Ozempic, Wegovy,

A limitation of the trial is the short duration, which does not permit conclusions on long-term safety

The mechanisms likely involve modulation of Na+/K+ ATPase activity in the choroid plexus, improvement in hypothalamic function, and reduction in inflammatory mediators [2, 3, 21, 22]

Ask a doctor before use if you have: Stomach pain, nausea, vomiting, or noticed a sudden change in bowel habits that lasts over 2 weeks

Quick Answer: Weight loss injections can cause fatigue, with clinical trials showing tiredness in 11.4% of semaglutide users and 7.2-10.8% of tirzepatide users compared to lower rates in placebo groups

And rarely, patients using Ozempic may experience more severe side effects such as: Allergic reactions (including hives, swelling, and difficulty breathing) Pancreatitis (inflammation of the pancreas) Kidney problems If you experience any of these side effects, it's important to stop taking Ozempic and consult with your doctor immediately

Semaglutide carries an FDA boxed warning based on rodent studies and is not recommended for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)